Integer Holdings Corporation $ITGR Shares Sold by Amundi

Key Points

• Amundi has reduced its stake in Integer Holdings Corporation by 19.4%, now holding 14,000 shares valued at approximately $1.625 million.
• Several institutional investors have increased their investments in Integer, with Paradigm Capital Management increasing its holdings by 426.2%, now owning 22,100 shares valued at around $2.608 million.
• Analysts are generally optimistic, with the stock receiving multiple upgrades, including a strong-buy rating from Citigroup, and a consensus target price of $140.25.

Amundi lessened its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 19.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,000 shares of the medical equipment provider's stock after selling 3,372 shares during the period. Amundi's holdings in Integer were worth $1,625,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vaughan Nelson Investment Management L.P. purchased a new stake in Integer during the 1st quarter valued at $33,337,000. Nuveen LLC purchased a new stake in Integer during the 1st quarter valued at $17,634,000. GAMMA Investing LLC boosted its position in Integer by 8,697.6% during the 1st quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider's stock valued at $92,190,000 after buying an additional 77,235 shares during the period. The Manufacturers Life Insurance Company boosted its position in Integer by 40.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 213,741 shares of the medical equipment provider's stock valued at $25,224,000 after buying an additional 61,273 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Integer during the 4th quarter valued at $7,889,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Truist Financial dropped their price target on shares of Integer from $145.00 to $137.00 and set a "buy" rating for the company in a research report on Friday, July 25th. Raymond James Financial dropped their price target on shares of Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research report on Friday, July 25th. Wells Fargo & Company decreased their price objective on shares of Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a report on Friday, July 25th. Finally, Wall Street Zen upgraded shares of Integer from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Integer currently has an average rating of "Buy" and a consensus target price of $140.25.

Integer Stock Down 1.2%

NYSE:ITGR traded down $1.23 on Monday, reaching $100.11. 654,541 shares of the stock traded hands, compared to its average volume of 289,350. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 44.10, a PEG ratio of 0.80 and a beta of 1.03. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. Integer Holdings Corporation has a 12 month low of $99.73 and a 12 month high of $146.36. The company's fifty day simple moving average is $109.19 and its 200 day simple moving average is $115.67.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The company had revenue of $476.00 million for the quarter, compared to analysts' expectations of $464.37 million. During the same quarter last year, the firm posted $1.30 earnings per share. Integer's revenue for the quarter was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Equities analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.